Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Gastrointestinal 2Thoracic 1Sarcoma 1Plasma cell 1Other neoplasm 1NET 1Myeloid 1Endocrine 1Dermatologic 1CNS 1Breast 1

Conditions

Multiple Myeloma 1663Neoplasms, Plasma Cell 415Lymphoma, Non-Hodgkin 311Lymphoma 283Hodgkin Disease 281Leukemia, Lymphocytic, Chronic, B-Cell 274Precursor Cell Lymphoblastic Leukemia-Lymphoma 246Leukemia, Myeloid, Acute 223Leukemia 220Lymphoma, Mantle-Cell 196Lymphoma, Large B-Cell, Diffuse 196Lymphoma, Follicular 196Myelodysplastic Syndromes 194Recurrence 185Lymphoma, B-Cell, Marginal Zone 178Burkitt Lymphoma 172Lymphoma, Large-Cell, Immunoblastic 161Myeloproliferative Disorders 146Leukemia, Myeloid, Chronic-Phase 134Leukemia, Myeloid, Accelerated Phase 122Primary Myelofibrosis 121Immunoglobulin Light-chain Amyloidosis 120Waldenstrom Macroglobulinemia 119Lymphoma, T-Cell, Cutaneous 119Blast Crisis 114Leukemia, Myelomonocytic, Chronic 105Sezary Syndrome 100Mycosis Fungoides 100Neoplasms 97Leukemia, Hairy Cell 95

Interventions

Zoledronic Acid 1Denosumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neoplastic Processes × Plasma cell × Clear all
NCT01345019 2022-11-08

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma

Amgen

Phase 3 Completed
1,718 enrolled 22 charts
Other hematologic neoplasmPlasma cellSarcoma

Blood Protein Disorders, Bone Diseases, Bone Marrow Diseases, Bone Neoplasms, Hematologic Diseases, Multiple Myeloma, Neoplasm Metastasis, Neoplasms, Neoplastic Processes, Paraproteinemias, Spinal Cord Compression, Hematologic Neoplasms, Fractures, Bone, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡